ArticleBMC pharmacology & toxicology2026
Integrating machine learning and retrospective cohort to explore the effects of AEDs on the prognosis of LGG and identify related molecular targets.
Article in BMC pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antiepileptic drugs (AEDs) were frequently employed in glioma patients, especially those with low-grade glioma (LGG), in which epilepsy manifested in roughly 70-90% of cases. It has been reported that some AEDs can improve the survival of glioma patients. However, the molecular mechanisms of AEDs through which affect LGG prognosis remained unclear. Therefore, this study integrated 105 targets of 10 AEDs, by using machine learning, molecular docking, a retrospective clinical cohort, and in vitro experiments to clarify the biological mechanisms through which AEDs affect LGG prognosis. Our study established a reliable 13-gene AEDs-related LGG prognostic model. Carbamazepine, Oxcarbazepine and Lacosamide were supposed to improve the OS by inhibiting the hazard factor SCN9A. Phenobarbital was supposed to restrict the OS by inhibiting the identified protectors GRIN2C and GRIN3A. Molecular docking visualized the strong affinities between the above drugs and targets. Retrospective cohort further verified our speculation about the effect of the above drugs on the prognosis of LGG. In vitro experiments demonstrated that inhibiting SCN9A, a common targets for most AEDs, could suppress LGG cells malignant behaviors; while the suppression of GRIN2C and GRIN3A enhanced the malignant behaviors of LGG cells. This study provided guidance for individualized AEDs selection for LGG patients, and provide new insights into the potential biological functions and molecular mechanisms of AEDs affecting LGG.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.